15 Recruiting Bladder Cancer Phase 1 Clinical Trials
Active phase 1 studies for bladder cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Bladder Cancer studiesPhase 1 Studies for Bladder Cancer
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
📍 UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 0104) — Los Angeles, California
View Study & Checklist ➔Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
View Study & Checklist ➔Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
📍 Massachussetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
📍 UT Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
📍 Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge, New Jersey
View Study & Checklist ➔A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
📍 Michael G Oefelein Clinical Trials ( Site 0005) — Bakersfield, California
View Study & Checklist ➔Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
📍 Baylor St. Luke's Medical Center — Houston, Texas
View Study & Checklist ➔KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
📍 UCSF Medical Center at Mission Bay ( Site 5044) — San Francisco, California
View Study & Checklist ➔